Industries · Drug Discovery & Biotechnology
OMICS4 runs the wet-lab side of your discovery programs (target identification support, mechanism-of-action transcriptomics and translational biomarker sample workflows) via our in-house platforms, bookable end to end.
Platforms used in this field
Overview
OMICS4 generates the readouts behind discovery programmes: transcriptomic, genomic and protein-level, on coded samples, under NDA-governed workflows, scheduled so the data lands before the decision and not after it.
Platforms
Mechanism-of-action RNA sequencing across doses and timepoints.
Sequencing on models and cell lines.
Fast, precise readouts on a defined target set.
Protein-level confirmation of a transcript result.
Cell lines, treated cultures, animal tissue, plasma and extracted nucleic acid. Input and quality criteria are published per sample type. Plate-format submissions are supported for screening series, with the plate map carried through to the result tables.
Samples are received and processed under coded identifiers, so compound and target identity stay compartmentalized on the bench as well as in the report. Turnaround is scheduled against your stage gates and confirmed before you ship.
A QC report for every sample. Sequencing files and, where the service covers it, aligned and quantified outputs. Result tables for PCR and protein work. Exports in the formats your team already imports, and turnaround published per service.
Analysis, integration, biomarker discovery and modelling are not part of a platform booking. They are run by GenXMap’s computational team. Ask for them in the quote request and both are scoped together.
Analysis at GenXMapHave a project in this space?